<DOC>
	<DOCNO>NCT00275509</DOCNO>
	<brief_summary>The purpose study determine whether anti-T cell antibody , Thymoglobulin effective induction medication anti-IL-2R inhibitor daclizumab , kidney transplant recipient positive crossmatch live donor .</brief_summary>
	<brief_title>Induction Therapy Study Live Donor Kidney Transplant Recipients With Positive Crossmatch</brief_title>
	<detailed_description>Kidney transplantation widely recognize optimal therapy management end-stage renal disease . Presently , decease donor kidney wait list expand disproportionately number transplant procedure perform United States . To compound problem , many 1/3 patient list highly sensitize broad range potential donor . In order address problem , develop antibody depletion protocol permit transplantation patient positive crossmatch live donor . The protocol consist standard immunosuppressant therapy , plasmapheresis , intravenous immunoglobulin infusion . We successfully perform transplantation 100 patient low complication rate . Because patient expose donor 's HLA antigen high risk acute cellular acute antibody-mediated rejection . This intent prospective , randomize , open-label trial determine whether induction therapy ( i.e . therapy give time transplantation prophylaxis ) Thymoglobulin associate low 6-month incidence acute cellular antibody-mediated rejection standard therapy , daclizumab .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Adult ( 18 year old ) Endstage renal disease Identified positive lymphocytotoxic crossmatch flow cytometric crossmatch live donor Deceased donor recipient Pregnancy Active infection History cancer within past two year ( exception nonmelanomatous skin cancer ) History heparin induce thrombocytopenia Medical contraindication transplant procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>kidney</keyword>
	<keyword>transplantation</keyword>
	<keyword>positive crossmatch</keyword>
	<keyword>antibody mediate rejection</keyword>
	<keyword>rejection</keyword>
	<keyword>induction</keyword>
	<keyword>therapy</keyword>
	<keyword>trial</keyword>
</DOC>